Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene | IC50 | 50000.0 [1] | |
| Rottlerin | IC50 | 1900.0 [1] | |
| 2-(2-Quinolin-3-Ylpyridin-4-Yl)-1,5,6,7-Tetrahydro-4h-Pyrrolo[3,2-C]pyridin-4-One | IC50 | 81.0 [1], 100.0 [2] | |
| (4-Morpholin-4-ylphenyl)-[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amine | IC50 | 816.0 [1], 2608.0 [2] | |
| 4-[8-(4-Morpholin-4-ylanilino)imidazo[1,2-a]pyrazin-5-yl]benzamide | IC50 | 914.0 [1], 1370.0 [2] | |
MLA | "Quest Database™ MAP kinase-activated protein kinase 5 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 4 Apr. 2026, https://www.aatbio.com/data-sets/map-kinase-activated-protein-kinase-5-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, April 4). Quest Database™ MAP kinase-activated protein kinase 5 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/map-kinase-activated-protein-kinase-5-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |